港股异动 | 礼邦医药-B(09637)飙升逾46% AP308获FDA临床许可及国内受理 全球化布局价值有望兑现
Last Update:
20 10 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.